Indian Olympic hope Sumit Sangwan banned for a year after testing positive for banned substance; will miss Tokyo 2020

Image Courtesy: Express Photo/NBC Nightly News

While the world of eyeing for the inauguration of the Tokyo Summer Olympics in July 2020, there has been an unfortunate mishap for India in the sport of boxing. Sumit Sangwan, who had all the expectations on his shoulders to bring home a medal in boxing, has faced a ban after the accusations against him of doping were proven right, and the ban will prohobit him to participate in the men’s trials for the Olympic main event next year.

Image Courtesy: Express Photo/NBC Nightly News

Yesterday, the National Anti Doping Agency (NADA) confirmed that Sangwan’s test results were positive. Back in October at the senior nationals in Baddi, Himachal Pradesh, traces of acetazolamide were detected in Sangwan’s urine sample. Acetazolamide, which is used to treat epilepsy, altitude sickness and heart failure, is a prohibited substance listed under S5 of WADA’s 2019 prohibited list as a diuretic and masking agent.

On 26th December, the Anti Doping Disciplinary Panel (ADDP) of NADA issued the ban on the 26 year old for a year, until 25th December 2020. Which means, the light heavyweight puglist will not be allowed to take part in the men’s selection qualifier for the Tokyo Olympics, which will run from 24th July to 9th August.

At yesterday’s hearing, Sangwan was imposed with violation of ADDP’s anti doping rule, but his ban duration was waived off to 12 months instead of the regular 4 year.

The statement that was issued at the hearing was: “The Hearing Panel holds that since Athlete in the present case was negligent in consuming the specified prohibited substance without verifying its composition and elements and elements and without disclosing same in the doping form, he is liable for sanctions under Article 10.5.1 for ineligibility period of 1 year.”

The defense lawyer team had convinced that the intake was unintentional. To treat an eye infection, a private doctor had prescribed Sangwan an ointment named Cap IOPAR – SR, which contained acetazolamide.

However, the 91 kg category boxer has stated that he will He will be making an appeal to the Higher Authorities, in hopes of lifting his ban and getting him a smooth entry into the 020 Olympics.

In April 2012, Sangwan achieved fandom after securing a Gold medal at the Asian Olympic Qualifiers in Astana, Kazakhstan. He also took part in the AIBA World Boxing Championships in Almaty, but was defeated in the quarter finals by Uzbekistani boxer Adilbek Niyazymbetov.

Also read-

Olympics: IOA President Narinder Batra lays out the future plans for Indian Athletes

Nikhat Zareen calls for a trial bout against Mary Kom to decide who will represent India in Tokyo 2020